Symptoms in the menopausal transition: Hormone and behavioral correlates

Obstetrics and Gynecology

Volumn 111, Issue 1, 2008, Pages 127-136

  Freeman, Ellen W ^a,b   Sammel, Mary D ^a   Lin, Hui ^a   Gracia, Clarisa R ^a   Kapoor, Shiv ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Department of Obstetrics/Gynecology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; FOLLITROPIN; SEX HORMONE; TESTOSTERONE;

ADULT; ANXIETY; ARTICLE; CONCENTRATION LOSS; CORRELATION ANALYSIS; FEMALE; HEADACHE; HORMONE BLOOD LEVEL; HUMAN; IRRITABILITY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MENOPAUSE; MOOD CHANGE; POSTMENOPAUSE; PREMENOPAUSE; PREMENSTRUAL SYNDROME; PRIORITY JOURNAL; RACE; RISK FACTOR; SMOKING; STRESS; SYMPTOMATOLOGY;

ADULT; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; FOLLICULAR PHASE; HEADACHE; HEALTH SURVEYS; HUMANS; IRRITABLE MOOD; LONGITUDINAL STUDIES; MIDDLE AGED; PERIMENOPAUSE; PREMENSTRUAL SYNDROME; TESTOSTERONE;

EID: 37549060313     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.AOG.0000295867.06184.b1     Document Type: Article

References (33)

1. National Institutes of Health. National Institutes of Health State-of-the-Science Conference statement: management of menopause-related symptoms. Ann Intern Med 2005;142:1003-13.
2. Freeman EW, Sammel MD, Lin H, Gracia CR, Pien GW, Nelson DB, et al. Symptoms associated with menopausal transition and reproductive hormones in midlife women. Obstet Gynecol 2007;110:230-40.
3. Freeman EW, Sammel MD, Liu L, Martin P. Psychometric properties of a menopausal symptom list. Menopause 2003;10:258-65.
4. Freeman EW, Sammel MD, Gracia CR, Kapoor S, Lin H, Liu L, et al. Follicular phase hormone levels and menstrual bleeding status in the approach to menopause. Fertil Steril 2005;83:383-92.
5. Freeman EW, Sammel MD, Liu L, Gracia CR, Nelson DB, Hollander L. Hormones and menopausal status as predictors of depression in women in transition to menopause. Arch Gen Psychiatry 2004;6:62-70.
6. Spitzer RL, Williams JB, Kroenke K, Linzer M, deGruy FV 3rd, Hahn SR, et al. Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study. JAMA 1994;272:1749-56.
7. Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA 1999;282:1737-44.
8. Nelson DB, Sammel MD, Freeman EW, Liu L, Langan E, Gracia CR. Predicting participation in prospective studies of ovarian aging. Menopause 2004;11:543-8.
9. Soules MR, Sherman S, Parrott E, Rebar R, Santoro N, Utian W, et al. Executive summary: Stages of Reproductive Aging Workshop (STRAW). Fertil Steril 2001;76:874-8.
10. Harlow BL, Wise LA, Otto MW, Soares CN, Cohen LS. Depression and its influence on reproductive endocrine and menstrual cycle markers associated with perimenopause: the Harvard Study of Moods and Cycles. Arch Gen Psychiatry 2003;60:29-36.
11. Bromberger JT, Assmann SF, Avis NE, Schocken M, Kravitz HM, Cordal A. Persistent mood symptoms in a multiethnic community cohort of pre- and perimenopausal women. Am J Epidemiol 2003;158:347-56.
12. Santoro N, Lasley B, McConnell D, Allsworth J, Crawford S, Gold EB, et al. Body size and ethnicity are associated with menstrual cycle alterations in women in the early menopausal transition: The Study of Women's Health across the Nation (SWAN) Daily Hormone Study. J Clin Endocrinol Metab 2004;89:2622-31.
13. Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav 1983;24:385-96.
14. McCullagh P, Nelder JA. Generalized linear models. 2nd ed. New York (NY):Chapman & Hall; 1989.
15. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986;73:13-22.
16. Facchinetti F, La Marca A. Headaches, migraines and premenstrual syndrome. Gynaecol Forum 2006;11:10-13.
17. Wang SJ, Fuh JL, Lu SR, Juang KD, Wang PH. Migraine prevalence during menopausal transition. Headache 2003;43:470-8.
18. Nappi RE, Cagnacci A, Granella F, Piccinini F, Polatti F, Facchinetti F. Course of primary headaches during hormone replacement therapy. Maturitas 2001;38:157-63.
19. Eriksson E, Andersch B, Ho HP, Landen M, Sundblad C. Diagnosis and treatment of premenstrual dysphoria. J Clin Psychiatry 2002;63 suppl:16-23.
20. Schmidt PJ, Nieman LK, Danaceau MA, Adams LF, Rubinow DR. Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. N Engl J Med 1998;338:209-16.
21. Freeman EW, Sammel MD, Rinaudo PJ, Sheng L. Premenstrual syndrome as a predictor of menopausal symptoms. Obstet Gynecol 2004;103:960-6.
22. Stewart DE, Boydell KM. Psychologic distress during menopause: associations across the reproductive cycle. Int J Psychiatry Med 1993;23:157-62.
23. Guthrie JR, Dennerstein L, Hopper JL, Burger HG. Hot flushes, menstrual status, and hormone levels in a population-based sample of midlife women. Obstet Gynecol 1996;88:437-42.
24. Dennerstein L, Lehert P, Burger H, Dudley E. Mood and the menopausal transition. J Nerv Ment Dis 1999;187:685-91.
25. Gracia CR, Sammel MD, Freeman EW, Lin H, Langan E, Kapoor S, et al. Defining menopause status: creation of a new definition to identify the early changes of the menopausal transition. Menopause 2005;12:128-35.
26. Freeman EW, Sammel MD, Lin H, Nelson DB. Associations of hormones and menopausal status with depressed mood in women with no history of depression. Arch Gen Psychiatry 2006;63:375-82.
27. North American Menopause Society. Estrogen and progestogen use in peri- and postmenopausal women: March 2007 position statement of The North American Menopause Society. Menopause 2007;14:168-82.
28. Cohen LS, Soares CN, Joffe H. Diagnosis and management of mood disorders during the menopausal transition. Am J Med 2005;118 suppl:93-7.
29. Steiner M, Pearlstein T, Cohen LS, Endicott J, Kornstein SG, Roberts C, et al. Expert guidelines for the treatment of severe PMS, PMDD, and comorbidities: the role of SSRIs. J Womens Health (Larchmt) 2006;15:57-69.
30. Rapkin AJ. New treatment approaches for premenstrual disorders. Am J Manag Care 2005;11:S480-91.
31. Yonkers KA, Brown C, Pearlstein TB, Foegh M, Sampson-Landers C, Rapkin A. Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder. Obstet Gynecol 2005;106:492-501.
32. Freeman EW, Sammel MD, Gracia CR, Kapoor S, Ferdousi T. The role of anxiety and hormonal changes in menopausal hot flashes. Menopause 2005;12:258-66.
33. Savitz DA, Olshan AF. Multiple comparisons and related issues in the interpretation of epidemiologic data. Am J Epidemiol 1995;142:904-8.